Published in J Biol Chem on March 10, 1978
Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol (1992) 1.50
Inhibition of prolyl 4-hydroxylase in vitro and in vivo by members of a novel series of phenanthrolinones. Biochem J (2001) 0.95
Independent secretion of proteoglycans and collagens in chick chondrocyte cultures during acute ascorbic acid treatment. Biochem J (1990) 0.80
Biosynthesis of recombinant human pro-alpha 1(III) chains in a baculovirus expression system: production of disulphide-bonded and non-disulphide-bonded species containing full-length triple helices. Biochem J (1995) 0.75
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med (1998) 4.08
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol (1992) 2.33
Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci U S A (1991) 2.24
Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J (1987) 2.23
NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage (2006) 2.07
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasia. N Engl J Med (1990) 1.93
A transport form of collagen from embryonic tendon: electron microscopic demonstration of an NH 2 -terminal extension and evidence suggesting the presence of cystine in the molecule (chick embryo-tropocollagen-gel filtration). Proc Natl Acad Sci U S A (1972) 1.79
Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest (1984) 1.70
Endoluminal ultrasonography of the distal esophagus in systemic sclerosis. Gastroenterology (1993) 1.60
A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. Genome Res (1996) 1.57
Inhibition of collagen synthesis by mononuclear cell supernates. J Exp Med (1979) 1.55
Stimulation of normal human fibroblast collagen production and processing by transforming growth factor-beta. Biochem Biophys Res Commun (1986) 1.51
The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med (1992) 1.46
Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis. J Rheumatol (1990) 1.46
Genetic linkage analysis of hereditary arthro-ophthalmopathy (Stickler syndrome) and the type II procollagen gene. Am J Hum Genet (1989) 1.44
Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Arthritis Rheum (1992) 1.41
Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts. Biochem J (1986) 1.37
Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. Biochem Biophys Res Commun (1977) 1.36
Structure of cDNA clones coding for human type II procollagen. The alpha 1(II) chain is more similar to the alpha 1(I) chain than two other alpha chains of fibrillar collagens. Biochem J (1989) 1.31
Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem Biophys Res Commun (1984) 1.27
Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology (1995) 1.25
Experimental silicosis: morphologic and biochemical abnormalities produced by intratracheal instillation of quartz into guinea pig lungs. Am J Pathol (1980) 1.25
Systemic sclerosis after augmentation mammoplasty with silicone implants. Ann Intern Med (1989) 1.23
Cell-mediated immunity in interstitial nephritis. III. T lymphocyte-mediated fibroblast proliferation and collagen synthesis: an immune mechanism for renal fibrogenesis. J Immunol (1980) 1.22
Determination of an epitope of the diffuse systemic sclerosis marker antigen DNA topoisomerase I: sequence similarity with retroviral p30gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci U S A (1989) 1.21
Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp Cell Res (1998) 1.20
Inhibition of excessive scleroderma fibroblast collagen production by recombinant gamma-interferon. Association with a coordinate decrease in types I and III procollagen messenger RNA levels. Arthritis Rheum (1986) 1.19
The regulation of lung fibroblast proliferation by alveolar macrophages in experimental silicosis. Am Rev Respir Dis (1984) 1.19
Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage (2003) 1.19
Biosynthesis of a low molecular weight collagen by rabbit growth plate cartilage organ cultures. Coll Relat Res (1983) 1.18
Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage (2007) 1.16
Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy. Clin Exp Immunol (1987) 1.15
The Tight skin mouse: demonstration of mutant fibrillin-1 production and assembly into abnormal microfibrils. J Cell Biol (1998) 1.10
Transforming growth factor-beta stimulation of lung fibroblast prostaglandin E2 production. J Biol Chem (1989) 1.10
Formation of nodular structures resembling mature articular cartilage in long-term primary cultures of human fetal epiphyseal chondrocytes on a hydrogel substrate. Arthritis Rheum (1994) 1.10
Intracellular collagen and protocollagen from embryonic tendon cells. J Biol Chem (1973) 1.09
Evaluation of transforming growth factor beta and type I procollagen gene expression in fibrotic skin diseases by in situ hybridization. J Invest Dermatol (1990) 1.09
Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci U S A (1992) 1.08
Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. Osteoarthritis Cartilage (1998) 1.06
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Arthritis Rheum (1998) 1.05
Genetic linkage mapping of multiple epiphyseal dysplasia to the pericentromeric region of chromosome 19. Am J Hum Genet (1994) 1.04
Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. J Clin Invest (1991) 1.04
Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum (1990) 1.03
Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest (1994) 1.03
Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc Natl Acad Sci U S A (1986) 1.03
Elevated expression of beta 1 and beta 2 integrins, intercellular adhesion molecule 1, and endothelial leukocyte adhesion molecule 1 in the skin of patients with systemic sclerosis of recent onset. Arthritis Rheum (1992) 1.02
Biosynthetic expression of type X collagen in embryonic chick sternum cartilage during development. J Biol Chem (1986) 1.01
Identification of two new collagen alpha-chains in extracts of lathyritic chick embryo tendons. Biochem Biophys Res Commun (1978) 1.00
Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro. Gene (1998) 0.98
A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease. J Rheumatol (1998) 0.98
Scleroderma-like alterations in collagen metabolism occurring in the TSK (tight skin) mouse. Arthritis Rheum (1984) 0.98
Exaggerated radiation-induced fibrosis in patients with systemic sclerosis. JAMA (1991) 0.98
Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest (1990) 0.98
Increased sensitivity of scleroderma fibroblasts in culture to stimulation of protein and collagen synthesis by serum. Biochem Biophys Res Commun (1977) 0.97
PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun (1987) 0.97
Recombinant gamma, alpha, and beta interferon regulation of human lung fibroblast proliferation. Am Rev Respir Dis (1987) 0.96
Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol (2000) 0.96
Identification of a mutation in type X collagen in a family with Schmid metaphyseal chondrodysplasia. Hum Mol Genet (1994) 0.95
Type X collagen alterations in rachitic chick epiphyseal growth cartilage. J Biol Chem (1988) 0.95
Increased collagen biosynthesis and increased expression of type I and type III procollagen genes in tight skin (TSK) mouse fibroblasts. J Biol Chem (1986) 0.95
Increased biosynthesis of glycosaminoglycans by scleroderma fibroblasts in culture. Arthritis Rheum (1984) 0.95
Positive regulation of human alpha 1 (I) collagen promoter activity by transcription factor Sp1. Gene (1995) 0.94
Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes. Arthritis Rheum (1998) 0.94
Impotence in progressively systemic sclerosis. Ann Intern Med (1981) 0.93
Quantitative analysis of type X-collagen biosynthesis by embryonic-chick sternal cartilage. Biochem J (1986) 0.93
Collagen synthesis by scleroderma fibroblasts in culture. Arthritis Rheum (1977) 0.93
Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. J Immunol (1995) 0.93
Exclusion of type II and type VI procollagen gene mutations in a five-generation family with multiple epiphyseal dysplasia. Am J Med Genet (1993) 0.92
Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis (2002) 0.92
Transcriptional modulation of cartilage-specific collagen gene expression by interferon gamma and tumour necrosis factor alpha in cultured human chondrocytes. Biochem J (1993) 0.92
Growth properties and biochemical characterization of collagens synthesized by adult rat heart fibroblasts in culture. J Mol Cell Cardiol (1992) 0.92
Biosynthesis of a disulphide-bonded short-chain collagen by calf growth-plate cartilage. Biochem J (1984) 0.91
Modulation of collagen gene expression: its relation to fibrosis in systemic sclerosis and other disorders. Ann Intern Med (1995) 0.91
Esophageal function in systemic sclerosis: a prospective evaluation of motility and acid reflux in 36 patients. Am J Gastroenterol (1993) 0.91
Expression of a human cartilage procollagen gene (COL2A1) in mouse 3T3 cells. J Biol Chem (1991) 0.90
Pulmonary function and gastroesophageal reflux in systemic sclerosis. Ann Intern Med (1994) 0.90
Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2. J Biol Chem (1993) 0.90
Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis. Immunogenetics (1997) 0.89
Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients. Semin Arthritis Rheum (1988) 0.89
Isolation, characterization, and localization of cardiac collagen type VI. Associations with other extracellular matrix components. Circ Res (1992) 0.88
Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med (1989) 0.88
Effects of temperature on conformation, hydroxylation, and secretion of chick tendon procollagen. J Biol Chem (1974) 0.88
Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum (1990) 0.88
Articular cartilage preservation and storage. I. Application of tissue culture techniques to the storage of viable articular cartilage. Arthritis Rheum (1979) 0.87
Characterization of pepsin-solubilized bovine heart-valve collagen. Biochem J (1978) 0.87
Heritable diseases of cartilage caused by mutations in collagen genes. J Rheumatol Suppl (1995) 0.87
Modulation of basal expression of the human alpha1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblasts. Matrix Biol (1998) 0.86
Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndrome. J Invest Dermatol (1991) 0.86
Detection and characterization of Sp1 binding activity in human chondrocytes and its alterations during chondrocyte dedifferentiation. J Biol Chem (1997) 0.86
Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I. Arthritis Rheum (2000) 0.86
CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts. Arthritis Rheum (2000) 0.86
TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol (1995) 0.86